Molnupiravir

We have been living with COVID for a little over two years now but it feels like forever. We have seen how a prescription given to one family member became the prescription for the whole family and even friends. People hoarded medicines…

Aurobindo Pharma has launched molnupiravir 200mg, the anti-viral drug that recently got emergency use authorisation in India for COVID-19 treatment, under the Molnaflu brand, at almost ₹50 per capsule. The company’s product, a pack of 40…

The government has not added Merck's coronavirus pill in its national treatment protocol for the disease due to some "major safety concerns", Balram Bhargava, head of the state-run Indian Council of Medical Research, said at a…

Molnupiravir, developed by US-based biotechnology company Ridgeback Biotherapeutics in collaboration with US pharma giant Merck, was approved for emergency use in India on Tuesday…

Since the onset of novel coronavirus, drug manufacturing companies have been looking for ways to curb the spread of the virus and to minimize the implications of COVID-19 infection. While the launch of coronavirus vaccines was a great…

The government has approved Merck’s covid-19 pill and two more vaccines for emergency use as the world’s second-most populous country braces for a possible spike in coronavirus cases due to the rapidly spreading Omicron variant.…

Newly infected COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear.The challenge is getting…

The decision to grant an emergency use authorisation came a day after the agency gave a green light to a similar but more effective pill developed by Pfizer.…

MUMBAI : The national task force for covid-19 could soon review its clinical guidelines in anticipation of an Omicron wave, ahead of the US regulator approving new treatments and armed with knowledge of what drugs…

Merck is partnering with a pharmaceutical company in Ontario to make its oral COVID-19 antiviral pill in Canada. Merck, the maker of molnupiravir — which is still under Health Canada review — announced Monday it has reached an…